NASDAQ:RKTO Rocket One Inc. Common Stock (RKTO) Stock Price, News & Analysis $1.08 0.00 (0.00%) As of 06/18/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Rocket One Inc. Common Stock Stock (NASDAQ:RKTO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get RKTO alerts:Sign Up Key Stats Today's Range$1.00▼$1.1250-Day Range$0.51▼$2.2252-Week Range$0.49▼$2.45Volume1.88 million shsAverage Volume21.93 million shsMarket Capitalization$24.11 millionP/E RatioN/ADividend YieldN/APrice Target$5.00Consensus RatingHold Company Overview Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the acquisition, licensing and development of novel therapies for dermatological, central nervous system and other debilitating conditions. The company’s strategy emphasizes in-licensing late preclinical or early clinical assets with promising pharmacological profiles and leveraging formulation science to optimize delivery. Core to its approach is the design of topical and localized administration platforms intended to enhance drug penetration, sustain release and reduce systemic exposure. Hoth’s development pipeline encompasses multiple candidate programs addressing high-unmet-need areas such as atopic dermatitis, epidermolysis bullosa and oral mucositis. The company holds exclusive worldwide licenses for a range of small molecules and biological compounds sourced from leading academic institutions and research organizations. By advancing these assets through preclinical studies and early-stage clinical trials, Hoth aims to validate therapeutic potential and move products toward regulatory milestones and eventual commercialization. Founded in 2018 and headquartered in New York, Hoth Therapeutics operates through strategic collaborations with universities, entrepreneurial biotech firms and contract research organizations. The company’s management team brings expertise in drug development, regulatory affairs and commercial strategy, positioning Hoth to navigate the complexities of clinical advancement and market entry. With a focus on specialized delivery technologies and precision formulations, Hoth seeks to address unmet medical needs and deliver innovative treatment options to patients worldwide.AI Generated. May Contain Errors. Read More Rocket One Inc. Common Stock Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks36th Percentile Overall ScoreRKTO MarketRank™: Rocket One Inc. Common Stock scored higher than 36% of companies evaluated by MarketBeat, and ranked 652nd out of 852 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingRocket One Inc. Common Stock has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialRocket One Inc. Common Stock has a consensus price target of $5.00, representing about 363.0% upside from its current price of $1.08.Amount of Analyst CoverageRocket One Inc. Common Stock has only been the subject of 2 research reports in the past 90 days.Read more about Rocket One Inc. Common Stock's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Rocket One Inc. Common Stock is -1.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rocket One Inc. Common Stock is -1.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRocket One Inc. Common Stock has a P/B Ratio of 2.70. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Rocket One Inc. Common Stock's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted30.97% of the float of Rocket One Inc. Common Stock has been sold short.Short Interest Ratio / Days to CoverRocket One Inc. Common Stock has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rocket One Inc. Common Stock has recently increased by 701.20%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldRocket One Inc. Common Stock does not currently pay a dividend.Dividend GrowthRocket One Inc. Common Stock does not have a long track record of dividend growth. News and Social Media2.3 / 5News Sentiment-0.25 News SentimentRocket One Inc. Common Stock has a news sentiment score of -0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Rocket One Inc. Common Stock this week, compared to 2 articles on an average week.Search Interest28 people have searched for RKTO on MarketBeat in the last 30 days. MarketBeat Follows5 people have added Rocket One Inc. Common Stock to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days. Company Ownership0.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Rocket One Inc. Common Stock insiders have not sold or bought any company stock.Percentage Held by Insiders6.92% of the stock of Rocket One Inc. Common Stock is held by insiders.Percentage Held by Institutions7.08% of the stock of Rocket One Inc. Common Stock is held by institutions.Read more about Rocket One Inc. Common Stock's insider trading history. Receive RKTO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rocket One Inc. Common Stock and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RKTO Stock News HeadlinesRocket One Reports Approximately $8.4 Million in Cash and Cash Equivalents and Outlines Strategy Across AI Infrastructure, Spintronic Computing for Space and Defense MarketsJune 15, 2026 | prnewswire.comSpace Stocks Get Torched: Short Seller Calls Them 'Sci-Fi Wishes'June 12, 2026 | benzinga.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.June 19 at 1:00 AM | Banyan Hill Publishing (Ad)Rocket One (RKTO) stock is trending after hours as retired NASA astronaut joins advisory board: Here's what you need to knowJune 12, 2026 | msn.comZentalis Pharmaceuticals (NASDAQ:ZNTL) vs. Rocket One Inc. Common Stock (NASDAQ:RKTO) Head to Head SurveyJune 12, 2026 | americanbankingnews.comROCKET ONE APPOINTS MAJOR GENERAL MALCOLM B. FROST (RET.June 3, 2026 | prnewswire.comRKTO Rocket One Inc.May 30, 2026 | seekingalpha.comRocket One Inc.May 30, 2026 | cnn.comSee More Headlines RKTO Stock Analysis - Frequently Asked Questions How have RKTO shares performed this year? Rocket One Inc. Common Stock's stock was trading at $0.99 on January 1st, 2026. Since then, RKTO stock has increased by 9.1% and is now trading at $1.08. How were Rocket One Inc. Common Stock's earnings last quarter? Rocket One Inc. Common Stock (NASDAQ:RKTO) posted its quarterly earnings results on Friday, May, 15th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.14) by $0.03. When did Rocket One Inc. Common Stock's stock split? Rocket One Inc. Common Stock shares reverse split on the morning of Wednesday, October 26th 2022.The 1-25 reverse split was announced on Wednesday, October 26th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 26th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. Who are Rocket One Inc. Common Stock's major shareholders? Rocket One Inc. Common Stock's top institutional shareholders include Lido Advisors LLC (0.20%). View institutional ownership trends. How do I buy shares of Rocket One Inc. Common Stock? Shares of RKTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Rocket One Inc. Common Stock own? Based on aggregate information from My MarketBeat watchlists, some other companies that Rocket One Inc. Common Stock investors own include Predictive Oncology (POAI), JPMorgan Chase & Co. (JPM), Abbott Laboratories (ABT), Ford Motor (F), Meta Platforms (META), NVIDIA (NVDA) and Zomedica (ZOM). Company Calendar Last Earnings5/15/2026Today6/19/2026Next Earnings (Estimated)9/02/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1w+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 For the last 7 days, RKTO's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:RKTO Previous SymbolNASDAQ:HOTH CIK1711786 Webwww.hoththerapeutics.com Phone(646) 756-2997FaxN/AEmployees4Year FoundedN/APrice Target and Rating Average Price Target for Rocket One Inc. Common Stock$5.00 High Price Target$5.00 Low Price Target$5.00 Potential Upside/Downside+363.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($0.80) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.47 million Net MarginsN/A Pretax MarginN/A Return on Equity-165.25% Return on Assets-143.61% Debt Debt-to-Equity RatioN/A Current Ratio3.39 Quick Ratio3.39 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.40 per share Price / Book2.70Miscellaneous Outstanding Shares22,320,000Free Float20,777,000Market Cap$24.11 million OptionableNot Optionable Beta0.89 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:RKTO) was last updated on 6/19/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...Behind the Markets | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket One Inc. Common Stock Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket One Inc. Common Stock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.